John D. Harling

6.6k citations
51 papers · 4.1k · 2 hit papers · h-index 25

Impact in

    • TGF-β signaling in diseases
    • Protein Degradation and Inhibitors
    • Ubiquitin and proteasome pathways
    • Pluripotent Stem Cells Research
    • Renal and related cancers
    • Connective Tissue Growth Factor Research
  • Oncology top 5%
    • Peptidase Inhibition and Analysis

Papers in

    • Protein Degradation and Inhibitors 16
    • Ubiquitin and proteasome pathways 15
    • TGF-β signaling in diseases 4
    • Synthetic Organic Chemistry Methods 4
    • Oxidative Organic Chemistry Reactions 3

John D. Harling

51 papers receiving 4.0k citations

John D. Harling's Hit Papers

SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7 2002 · 1.4k citations
1.4k0+8+16Years since publication4008001.2k

Peers

John D. Harling
Comparison fields: 5 of 127
  • Molecular Biology 2.9k
  • Oncology 903
  • Hematology 304
  • Organic Chemistry 621
  • Immunology and Allergy 128
Replace Aykut Üren with:
Aykut Üren United States
Seth J. Field United States
Jos Domen United States
Stephen A. Kaufman United States
Gopal P. Sapkota United Kingdom
Brian Yeh United States
Joan Levy United States
Catrin Pritchard United Kingdom
William J. LaRochelle United States
Adam P. Silverman United States
John D. Harling relative to Aykut Üren United States Aykut Üren's profile →
Citations per field
00.5×4.9×
Aykut Üren · 1×
Citations per year

Countries citing papers authored by John D. Harling

Since Specialization
Citations

This map shows the geographic impact of John D. Harling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John D. Harling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John D. Harling more than expected).

Fields of papers citing papers by John D. Harling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John D. Harling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John D. Harling. The network helps show where John D. Harling may publish in the future.

Co-authors

The 25 scholars most cited alongside John D. Harling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John D. Harling Line = papers co-authored together John D. Harling links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.

#Work
1
SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
Hit paper breakdown →
20021406
2
Inhibition of Transforming Growth Factor (TGF)-β1–Induced Extracellular Matrix with a Novel Inhibitor of the TGF-β Type I Receptor Kinase Activity: SB-431542
Hit paper breakdown →
2002544
3 2015342
4 2002267
5 2005153
6 2019134
7 2020107
8 2019100
9 202185
10 199271
11 202067
12 200450
13 202149
14 200138
15 200437
16 202036
17 202235
18 199033
19 200532
20 199932

About John D. Harling

John D. Harling is a scholar working on Molecular Biology, Organic Chemistry, Oncology, Hematology and Ecology, having authored 51 papers that have together received 4.1k indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (16 papers), Ubiquitin and proteasome pathways (15 papers), Multiple Myeloma Research and Treatments (8 papers), Peptidase Inhibition and Analysis (6 papers), Synthetic Organic Chemistry Methods (4 papers), TGF-β signaling in diseases (4 papers), Wildlife Ecology and Conservation (3 papers) and Oxidative Organic Chemistry Reactions (3 papers). The work is most often cited by research in Molecular Biology (2.9k citations), Oncology (903 citations), Hematology (304 citations), Organic Chemistry (621 citations) and Immunology and Allergy (128 citations). John D. Harling has collaborated with scholars based in United Kingdom, United States and Ireland. Frequent co-authors include Nicholas J. Laping, James F. Callahan, Laramie M. Gaster, Caroline S. Hill, Gareth J. Inman, Francisco José Nicolás, Alastair D. Reith, Eugene T. Grygielko, W. Martin and Christopher Tweed. Their work appears in journals such as Journal of Medicinal Chemistry, Tetrahedron, Bioorganic & Medicinal Chemistry Letters, ACS Chemical Biology and Chemical Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact